The World Market for Point of Care (POC) Diagnostics
NEW YORK, Jan. 8, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The World Market for Point of Care (POC) Diagnostics
http://www.reportlinker.com/p01080629/The-World-Market-for-Point-of-Care-POC-Diagnostics.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions, and many other factors.
Point of Care Testing (POCT) is attracting considerable investor and industry activity. This Kalorama Information report,
The World Market for Point of Care Diagnostics
, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.
As part of this report's coverage, the following data is included:
- Molecular POC Test Products and the Future of Molecular POC
- Self-Testing Point of Care Test Market by Category, Worldwide (Glucose, Infectious Diseases, Critical Care, Cardiac Markers, Hematology, Coagulation, Fecal Occult Blood, HbA1c, Cholesterol/Lipids, Drugs of Abuse, Pregnancy/Ovulation, Other)
- Professional Point of Care Testing Market by Test Category, Worldwide, 2011 and 2016 (Glucose, Pregnancy/Ovulation, Fecal occult blood, Coagulation, Drugs of abuse, Cholesterol, HIV, Other)
- Regional Breakout of POC Market (US, EU, Japan, ROW)
- Blood Glucose Monitoring Markets
- Small Footprint and POC Chemistry Systems
- Small Footprint and POC Hematology Systems
- Small Footprint and POC Immunoassay Systems
- Non-Invasive Testing Innovations
- Miniaturization and Microfluidics Innovations
- POC Test Revenues of Selected IVD Companies
- Selected Rapid HIV Tests on the Market
- Comparative Effectiveness, Healthcare Reform and Other Trends in IVD
- Hospital POCT, Physician Office POCT, Critical Care POCT
All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.
The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.
CHAPTER ONE: EXECUTIVE SUMMARY
Size of POC Market
Trends
CHAPTER TWO: INTRODUCTION
Introduction and DefinitionsAdvantages and Disadvantages of Point-of-Care Testing
CHAPTER THREE: TECHNOLOGY INNOVATIONS IN POINT-OF-CARE TESTING
Miniaturization and Microfluidics Technologies
Wireless Technology
Informatics
Molecular Diagnostics
CHAPTER FOUR: LOCATIONS FOR POINT-OF-CARE TESTING
POC Testing in Hospitals and ClinicsPhysicians' Office LaboratoriesRetail OutletsOther Professional POC TestingWorkplace TestingHome Monitoring - TelemedicineHome Self Testing
CHAPTER FIVE: POINT-OF-CARE TESTING MARKET ANALYSIS
Market Overview POC Markets – Current Markets and Market Forecasts
CHAPTER SIX: POINT-OF-CARE MARKET SEGMENTS
Diabetes Pregnancy and OvulationClinical ChemistryUrinalysisBlood GasInfectious DiseasesHematologyCoagulationCardiacDrug TestingAllergyPOC Testing Market of the Future - Molecular Diagnostics
CHAPTER SEVEN: HEALTHCARE ECONOMICS AND HEALTHCARE REFORM
Heathcare Economics and Outcomes Testing Healthcare Reform
CHAPTER EIGHT: COMPANY PROFILES – COMPANIES MARKETING POC TEST PRODUCTS
1 Step Detect Associates3M3test77 Elektronika Kft.A. Menarini DiagnosticsAbaxis, Inc.Abbott DiagnosticsAccuBioTech Co., Ltd.AccumetricsAccutechAcon LaboratoriesAcrongenomics Inc.Advanced Care ProductsAdvanced Microdevices Pvt. Ltd.Aerscher DiagnosticsAgaMetrix, Inc.Aimedics (Australia)Akers BiomedicalAlereAlfa Scientific Designs, Inc.Alfa Wassermann Diagnostic Technologies, LLCAlliance International Co., Ltd.All MedicusAmedica BiotechAmerican Bio Medica CorpAmerican Screening CorporationAmeriTekAmpcorAnalyticon Biotechnologies AGAni Biotech/Ani LaboratoriesApex Biotechnology Corp.Applied MicroarraysARJ Medical ARKRAY, Inc.Arlington Scientific, Inc.Artron LaboratoriesAspenBio Pharma, Inc.Ativa MedicalAtlas Genetics Atlas Link Biotech Co., Ltd.Atonomics A/SAudit DiagnosticsAutobio Diagnostics Co., Ltd.Aventir BiotechAxis-Shield plcAxxinAZOG, Inc.B.R.A.H.M.S. AGBayer Diabetes CareBD GeneOhmBeckman Coulter Inc.Becton, Dickinson and Company (BD)BestgenBioAssay Works, LLCBiocartisBioHelixBiohit HealthCareBioLand Technology Ltd. bioLytical Laboratories Inc.Biomagnetics Diagnostics CorporationBiomedix, Inc.BioMedomicsBiomerica, Inc.bioMerieux Inc.Bioptik Technology, IncBio-Rad Laboratories Inc.BioScanBioSence Medical DevicesBiosensiaBioSys Laboratories, Inc.BiotaBiotest MedicalBlue Cross Biomedical CompanyBoditech Med Inc.BodyTel Scientific, Inc.Boson Biotech Co., Ltd.Branan Medical Corporation BTNX IncCalypte Biomedical CorporationCambridge Sensors Ltd. and/or Cambridge Sensors USACepheidCERAGEM Medisys Inc.ChematicsChembio Diagnostic Systems, Inc.Clarity DiagnosticsClinical Innovations, LLCConcateno plcContraVac, Inc.CTK Biotech Inc.DENKA SEIKEN CO., LTD.DexCom, Inc.DFI Co., Ltd.Diabetech, LPDiabetes Sentry Products Inc.Diaglobal GmbHDiagnostics for All (DFA)Diagnostics for the Real World (DRW)DiaSys Diagnostic SystemsDiazyme LaboratoriesDxNAEcho Therapeutics, Inc.EKF-diagnostic GmbElitech GroupEnigma Diagnostics LimitedEntra Health SystemsEpinex Diagnostics Laboratories, Inc.Epocal, Inc.EUMED Biotechnology Co. Ltd.Fora CareGenBioGeneFluidicsGeneral Biologicals Corp.GenPrime, Inc.GluMetricsHeidelberger-Medical-Marketing GmbH (HMM GmbH)Helena Laboratories USAHema Diagnostic SystemsHemoCue, Inc. A Quest Diagnostic CompanyHemosureHoriba ABX S.A.Identa CorporationiLine MicrosystemsinBios International Inc.Innovative Biosensors, Inc.Instrumentation LaboratoryIntegrity Applications Ltd.International Technidyne Corp (ITC)Inverness Medical InnovationsInvestigenIonian TechnologiesIQuum, Inc.Jant PharmacalLifeAssays ABLifescan Inc.LifeSign LLCLiming Bio-products Co., Ltd.Magellan DiagnosticsMagnisenseMasimo CorporationmBio DiagnosticsMedMira Inc.Medtronic Inc.Meridian BioscienceMetaara Medical Technologies Incmicrofluidic ChipShop GmbHMicronics Inc.Micropoint Bioscience, Inc.Miraculins MP Biomedicals LLCMycroLab Pty Ltd.Nanomix, Inc.Nanosphere, Inc.Network Biosystems, Inc. (NetBio)Nexus Dx, Inc. (Subsidiary of Samsung Electronics Co.)Nipro DiagnosticsNoninvasive Medical Technologies, Inc.Nova BiomedicalOPKU HealthOPTI Medical Systems, Inc.OraSure Technologies, Inc.Orion DiagnosticaOrSense Ltd.Ortho Clinical DiagnosticsOxonica DiagnosticsPepex Biomedicalpes diagnosesysteme GmbHPlaCor, Inc.PointCare TechnologiesPolymedco, Inc.Polymer Technology Systems, Inc.Princeton Biomeditech CorpProbe Scientific LtdProdigy Diabetes CarePropper Manufacturing Co.Qiagen N.V.QuantuMDx GroupQuidel CorporationQuikTest USA, Inc. Quotient DiagnosticsRadiometer A/SRapid Pathogen ScreeningReLIA Diagnostic SystemsRennesens GmbHResponse Biomedical Corp.Rheonix, Inc.Roche DiagnosticsSAKAE CorporationSavyon DiagnosticsSekisui DiagnosticsSiemens Healthcare DiagnosticsSysmex CorporationThermo ScientificZonda, Inc.
Selected Tables
POC Sales by Test Category, Worldwide World Glucose Monitoring Sales by Company Selected Continuous Blood Glucose Monitoring Systems Selected OTC Pregnancy and Ovulation Tests Selected POC Clinical Chemistry Systems Selected Urinalysis POC Tests Selected POC Blood Gas Systems Selected Rapid Infectious Disease Tests Selected POC Coagulation Tests Selected Molecular Diagnostic Companies Targeting Rapid or POC Market
To order this report:In_Vitro_Diagnostic Industry: The World Market for Point of Care (POC) Diagnostics
CONTACT
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article